Immunogenicity 14294
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
INF2
Transcript ID
NM_032714
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (234 aa)
MSVKE
1
GAQRK
6
WAALK
11
EKLGP
16
QDSDP
21
TEANL
26
ESADP
31
ELCIR
36
LLQMP
41
SVVNY
46
SGLRK
51
RLEGS
56
DGGWM
61
VQFLE
66
QSGLD
71
LLLEA
76
LARLS
81
GRGVA
86
RISDA
91
LLQLT
96
CVSCV
101
RAVMN
106
SRQGI
111
EYILS
116
NQGYV
121
RQLSQ
126
ALDTS
131
NVMVK
136
KQVFE
141
LLAAL
146
CIYSP
151
EGHVL
156
TLDAL
161
DHYKT
166
VCSQQ
171
YRFSI
176
VMNEL
181
SGSDN
186
VPYVV
191
TLLSV
196
INAVI
201
LGPED
206
LRART
211
QLRNE
216
FIGLQ
221
LLDVL
226
ARLR
231
Mutation Information
DNA mutation:
None
Peptide Range:
184 ~ 208
Mut AA position:
196 (13 in Wild Type peptide)
Alignment
Wild Type:
"ELSGSDNVPYVVTLLSVINAVILGP
||||||||||||.||||||||||||
Mutant:
ELSGSDNVPYVVILLSVINAVILGP"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) INF2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay